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Cadmium activates AMPA and NMDA receptors with
M3 helix cysteine substitutions
Timothy J. Wilding and James E. Huettner
AMPA and NMDA receptors are ligand-gated ion channels that depolarize postsynaptic neurons when activated by the
neurotransmitter L-glutamate. Changes in the distribution and activity of these receptors underlie learning and memory, but
excessive change is associated with an array of neurological disorders, including cognitive impairment, developmental delay,
and epilepsy. All of the ionotropic glutamate receptors (iGluRs) exhibit similar tetrameric architecture, transmembrane
topology, and basic framework for activation; conformational changes induced by extracellular agonist binding deform and
splay open the inner helix bundle crossing that occludes ion flux through the channel. NMDA receptors require agonist
binding to all four subunits, whereas AMPA and closely related kainate receptors can open with less than complete occupancy.
In addition to conventional activation by agonist binding, we recently identified two locations along the inner helix of the GluK2
kainate receptor subunit where cysteine (Cys) substitution yields channels that are opened by exposure to cadmium ions,
independent of agonist site occupancy. Here, we generate AMPA and NMDA receptor subunits with homologous Cys
substitutions and demonstrate similar activation of the mutant receptors by Cd. Coexpression of the auxiliary subunit stargazin
enhanced Cd potency for activation of Cys-substituted GluA1 and altered occlusion upon treatment with sulfhydryl-reactive
MTS reagents. Mutant NMDA receptors displayed voltage-dependent Mg block of currents activated by agonist and/or Cd as
well as asymmetry between Cd effects on Cys-substituted GluN1 versus GluN2 subunits. In addition, Cd activation of each Cys-
substituted iGluR was inhibited by protons. These results, together with our earlier work on GluK2, reveal a novel mechanism
shared among the three different iGluR subtypes for prying open the gate that controls ion entry into the pore.
Introduction
Ionotropic glutamate receptors (iGluRs) are gated pores through
the plasma membrane that mediate neurotransmission at excita-
tory synapses in the central nervous system (Traynelis et al.,
2010). Each receptor is a modular tetramer with extracellular
amino-terminal and ligand-binding domains (ATD and LBD, re-
spectively), a pore-forming transmembrane domain (TMD), and a
cytoplasmic carboxy-terminal domain involved with trafficking
and regulation by intracellular proteins (Traynelis et al., 2010).
The three main iGluR subtypes named for the agonists kainate,
α-amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA),
and NMDA comprise separate sets of subunits that exhibit similar
transmembrane topology despite limited primary sequence
identity (Traynelis et al., 2010). In addition to their essential role
in normal physiology, increasing evidence highlights the detri-
mental consequences of aberrant iGluR activation resulting from
elevated extracellular glutamate (Bano and Ankarcrona, 2018),
de novo point mutations (Guzmán et al., 2017; Fernández-
Marmiesse et al., 2018; Fry et al., 2018; Li et al., 2016), or au-
toimmunemodulation of receptor activity (Gleichman et al., 2012).
Indeed, recent work to understand iGluR operation and identify
subtype-selective antagonists and allosteric modulators has been
fueled by the growing list of neuropathologies attributed to acute
or chronic iGluR hypo- or hyperactivation.
Much of the work on iGluR gating and permeation has fo-
cused on the TMD, which resembles an inverted potassium
channel (Kuner et al., 2003; Huettner 2015). Each of the four
subunits contributes a pore loop (M2) including a short helix and
open coil that dips into the plane of the membrane from the
cytoplasmic side and is flanked by inner (M3) and outer (M1)
transmembrane helices (Sobolevsky et al., 2009). All eukaryotic
iGluRs possess an additional transmembrane helix (M4) that
contacts M1 and M3 of the adjacent subunit (Terhag et al., 2010;
Salussolia et al., 2013). The gate for ion flux through the pore is
formed by a tight occlusion at the bundle crossing of the inner
(M3) helices (Twomey and Sobolevsky, 2018), which include a
conserved 9-amino acid (SYTANLAAF) motif in all of the iGluR
subunits (Kuner et al., 2003). Agonist binding to the extracellular
LBD opens iGluR channels by pulling on short linkers that distort
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the M3 helices at the bundle crossing (Chen et al., 2017; Twomey
et al., 2017), disrupting the occlusion zone to allow ions and water
into the central cavity. Despite this common framework, NMDA
and non-NMDA (AMPA/kainate) receptors exhibit significant
differences in their gating and permeation properties. For exam-
ple, activation of AMPA (Rosenmund et al., 1998; Smith andHowe,
2000) and kainate (Swanson et al., 2002; Fisher and Mott, 2011)
receptors does not require agonist binding to all four subunits,
whereas conventional diheteromeric NMDA receptors remain
closed unless all four subunit LBDs are occupied (Johnson and
Ascher, 1987; Kleckner and Dingledine, 1988), with glutamate
binding to the GluN2 subunits and glycine or D-serine binding to
GluN1 (Traynelis et al., 2010).
In addition to physiological gating by agonist binding to the
LBD,we recently identifiedmutations in theM3 helix of the GluK2
kainate receptor subunit that allow channels to be opened by
cadmium applied in the absence of LBD agonists (Wilding and
Huettner, 2019). Exposure to Cd produces rapid and reversible
activation of receptors that include subunits with Ala to Cys
substitution at position 8 in the SYTANLAAF motif (S = 1) or with
Leu to Cys substitution at position 10 immediately following this
motif (see Fig. 1 A). Here we analyze the effect of Cd exposure on
AMPA and NMDA receptors with homologous Cys substitutions.
Our results demonstrate activation by Cd in the absence of added
agonist and/or potentiation of agonist-evoked current by Cd
coapplication for both Cys substitutions. As we found for GluK2
kainate receptors (Wilding and Huettner, 2019), Cd exhibits
higher potency at AMPA and NMDA receptors with the A8C than
the L10C substitution. In addition, recordings from heteromeric
receptors confirmed that A8C or L10C replacement is not required
on all four subunits within the tetramer. Together, this work
identifies a novel mechanism shared among the three iGluR sub-
types for prying open the bundle-crossing gate (Wollmuth, 2019).
Materials and methods
cDNA constructs, cell culture, and transfection
Plasmids with DNA encoding WT AMPA and NMDA receptor
channels were generously provided by Drs. Steve Heinemann
(Salk Institute, La Jolla, CA), Peter Seeburg (Max Planck Insti-
tute, Heidelberg, Germany), Doris Patneau (Oklahoma State
University, Stillwater, OK), and Stefano Vicini (Georgetown
University, Washington, D.C.). Point mutations were generated
with the QuikChange XL system (Agilent) or by PCR (Lopez
et al., 2013). All constructs were verified by DNA sequencing.
HEK293 cells at 50–70% confluencewere transfected with 1–3 µg
plasmid DNA using lipofectamine 2000 (ThermoFisher). Coex-
pression of a plasmid encoding GFP was used to identify trans-
fected cells. One day after transfection, cells were dissociated
with protease and replated at low density on nitrocellulose-
treated 35-mm dishes (Wilding et al., 2008). Recordings were
obtained from green fluorescent cells 24–48 h after replating.
Electrophysiology
Whole-cell recordings were obtained on an inverted microscope
equipped with epifluorescent illumination. The culture dish
was perfused with Tyrode’s solution (in mM): 150 NaCl, 4 KCl,
Figure 1. AMPA receptor activation by Cd. (A) iGluR subunit sequence
alignment near the M3 helix bundle-crossing occlusion. Numbers on the right indi-
cate position of the final residue from the amino terminal methionine. Homologous
positions are numbered above the sequences relative to the first conserved residue in
the SYTANLAAF motif. Yellow highlights sequence identity. The A8 Lurcher site is
markedwith an asterisk. In the AMPA receptor closed state, theM3 helix extends to
approximately +17 and +12 in the A/C and B/D conformations, respectively, as de-
picted by gray cylinders above the sequence. (B andC)Current evoked by 50µMCd
alone (B) or togetherwith kainate (C) as a fraction of current evoked by kainate alone
(mean ± SEM, 6–33 cells per AMPA receptor construct). Data for GluK2were derived
fromWilding and Huettner (2019). Asterisks denote significant difference fromGluA1
(one-way ANOVA with post hoc Dunn’s comparison to control). Insets showwhole-
cell currents evoked by 100 µMkainate (KA, open bar) and 50 µMCd alone (red bar)
for homomeric GluA1 A8C (B) or by 50 µM Cd together with kainate (cyan bar) for
GluA1 L10C+ stargazin (C). Single exponential fits to the onset (red line) and recovery
(blue line) of Cd responses are shown in B (τ on = 540ms; τ off = 3.6 s) and C (τ on =
2.0 s; τ off = 7.5 s). Scale bars represent 30 s and 100 pA (B) or 400 pA (C).
Wilding and Huettner Journal of General Physiology 2 of 15
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2 CaCl2, 2 MgCl2, 10 glucose, and 10 HEPES, pH adjusted to 7.4
with NaOH. Borosilicate electrodes had an open tip resistance of
2–5 MOhm when filled with internal solution (in mM): 140 Cs-
glucuronate, 10 EGTA, 5 CsCl, 5 MgCl2, 5 ATP, 1 GTP, and 10
HEPES buffer, pH adjusted to 7.4 with CsOH. Agonists and/or Cd
were dissolved in 160 mM NaCl, 2 mM CaCl2 and 10 mM HEPES
(pH 7.4 with NaOH) and applied by local perfusion from an 8-
barrelled gravity-driven capillary pipette (Wilding et al., 2005).
Currents were recorded with an Axopatch 200A amplifier
(Molecular Devices) controlled by pClamp software.
Analysis
Current–voltage relations were generated and analyzed from
triangle wave ramps as described (Lopez et al., 2013). For
concentration–inhibition experiments, current recorded during
exposure to agonist plus Cd was plotted as a fraction of control
current evoked by agonist alone. Concentration–inhibition re-
sults were fit with the following equation: I/I control = 1 / [1 +
([Cd] / IC50)b], where IC50 is the Cd concentration producing
half-maximal inhibition and b is the slope factor or Hill coeffi-
cient. Steady-state currents evoked by Cd were normalized to
the maximal Cd response (I max) and fit with the following
equation: I/I max = {1 / [1 + (EC50 / [Cd])n]} / [1 + ([Cd] / IC50)b],
where EC50 and IC50 are the Cd concentrations producing half-
maximal activation and inhibition, respectively, and n and b are
the slope factors for activation and inhibition. In some cases, an
additional scaling factor was used to reflect the fact that steady-
state current never achieved themaximal level (I max) recorded
during the initial peak or tail response.
Results are reported as mean ± SEM, and significance was
assigned for P < 0.05. One-way and two-way ANOVA and t tests
were performed with SigmaStat (Systat Software). Curve fits
using different numbers of parameters were evaluated by the
ratio of residual variance test, F-statistic (Swartz et al., 1992).
Online supplemental material
Fig. S1 shows activation by kainate and inhibition by Cd of
whole-cell currents in HEK293 cells transfected with A7C
substituted GluK2(Q) and GluA1. Fig. S2 compares activation by
kainate or by glutamate plus cyclothiazide for GluA1WT, A8C, or
L10C with or without γ-2 transmembrane AMPA receptor reg-
ulatory protein (TARP) coexpression. Fig. S3 shows activation by
Cd compared with glutamate for A8C or L10C mutant GluA1
expressed alone or together with γ-2 TARP. Fig. S4 shows
current–voltage relations for agonist and Cd activated currents
mediated by GluA1 A8C and L10C. Fig. S5 shows Mg block of
NMDA receptors with L10C substitutions. Fig. S6 shows proton
inhibition of Cys-substituted non-NMDA receptor Cd activation.
Results
Cd activates AMPA receptors with M3 helix cysteine
(Cys) substitutions
GluK2 kainate receptors with Cys substitutions at the A8 and L10
position in the M3 helix occlusion zone (Fig. 1 A) can be directly
activated by exposure to Cd in the absence of agonist (Wilding
and Huettner, 2019). To determine whether this is a feature
unique to GluK2 or a general property shared among iGluR
subunits, we first analyzed the effect of 50 µMCd on homomeric
GluA1 AMPA receptors with homologous A8C or L10C sub-
stitutions (Fig. 1, B and C). In addition, we tested two other GluA1
M3 helix Cys substitutions (L-4C and A7C) that were shown to
be sensitive to Cd coapplication with agonist in previous work
on homomeric GluA1 receptors expressed in Xenopus laevis oo-
cytes (Sobolevsky et al., 2004). For the experiments in Fig. 1, we
expressed WT or mutant GluA1 subunits in HEK293 cells alone
or together with the γ-2 TARP, an auxiliary subunit that is also
known as stargazin (Greger et al., 2017). In cells that received
WT GluA1 50 µM Cd caused minimal change in the holding
current when applied alone at −80 mV and had little effect on
agonist-evoked current during coapplication with 100 µM kai-
nate (Fig. 1, B and C). In contrast, Cd alone reduced the consti-
tutive holding current recorded in cells expressing homomeric
A7C mutant receptors (Fig. S1) and directly activated current in
cells transfected with either the A8C or L10C mutations. In ad-
dition, coapplication of Cd with kainate revealed stronger inhi-
bition than WT GluA1 for receptors with the A7C substitution
but substantial potentiation for GluA1 bearing the L10C muta-
tion. In most cells, the onset and recovery of Cd-evoked re-
sponses were well described by single exponential functions,
although some cells exhibited a second slower kinetic compo-
nent that may reflect tighter Cd coordination (Fig. 1, B and C,
insets). When compared with homomeric mutant GluK2 kainate
receptors (Wilding and Huettner, 2019), 50 µM Cd coapplication
with agonist produced stronger inhibition of agonist-evoked
current for the A7C mutant of GluA1 than for GluK2, similar
potentiation for L10C substitution of GluA1 or GluK2, but weaker
potentiation for the A8C mutation of GluA1 versus GluK2 (Fig. 1
C). Together, these results show that A8C or L10C substitution
renders both AMPA and kainate receptors sensitive to activation
by Cd.
Coexpression of γ-2 TARP tended to reduce the action of Cd
relative to agonist alone. For example, Cd potentiated kainate-
evoked current ∼1.5-fold for GluA1 A8C expressed alone but had
no significant effect with stargazin coexpression. Because γ-2
TARP can enhance the efficacy of partial agonists, such as kai-
nate, for activation of WT receptors (Tomita et al., 2005;
Turetsky et al., 2005), we also tested for this effect on homo-
meric A8C or L10C mutant GluA1. Experiments summarized in
Fig. S2 confirmed the increase in kainate efficacy for WT GluA1
but revealed no difference in kainate relative to glutamate for
either the A8C or L10C mutants with γ-2 TARP coexpression
(Fig. S2). In addition, the positive allosteric modulator cyclo-
thiazide (Yamada and Tang, 1993) had almost no effect on
steady-state currents evoked by glutamate at receptors with A8C
substitution and caused weaker potentiation of receptors with
L10C substitution than occurs for WT GluA1 (Fig. S2). As shown
in Fig. S3 we also compared currents evoked by Cd and gluta-
mate. Co-transfection with γ-2 TARP had no effect on direct
activation of GluA1 A8C or L10C by Cd alone (Fig. S3), but re-
duced activation of both mutants by coapplication of Cd and
glutamate (Fig. S3) or of the L10C mutant by cyclothiazide and
glutamate (Fig. S2). Thus, agonist-gated currents mediated by
receptors with A8C or L10C substitutions exhibit less positive
Wilding and Huettner Journal of General Physiology 3 of 15
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allosteric modulation by Cd or cyclothiazide when γ-2 TARP is
coexpressed.
Concentration dependence of Cd activation and inhibition
Before evaluating the concentration dependence of Cd activation
at mutant receptors, we tested WT receptors with higher Cd
concentrations. As shown in Fig. 2, half-maximal inhibition of
kainate-evoked current mediated by WT GluA1 subunits ex-
pressed alone or together with γ-2 TARP required millimolar Cd
(see Mayer et al., 1989). Individual inhibition curve fits illus-
trated in Fig. 2 B yielded IC50 estimates of 1.1 ± 0.3 and 2.9 ±
1.3 mM or GluA1 alone and GluA1 plus γ-2 TARP, respectively,
but were not statistically superior to a simultaneous fit with a
single curve (IC50 = 2.1 ± 0.6 mM, b = 0.75 ± 0.15; P > 0.05,
F-statistic). Thus, millimolar concentrations of Cd inhibit ho-
momericWT GluA1 AMPA receptors and TARP coexpression has
minimal effect on the potency of Cd inhibition.
In contrast to WT GluA1, homomeric receptors formed by
GluA1 A8C displayed monotonic activation and recovery with
exposure to low Cd concentrations (<50 µM), whereas 400 µM
and 2 mM Cd elicited multiphasic currents with an initial peak
followed by decay to a lower steady-state plateau and prominent
tail current on Cd washout (Fig. 3 A). As for kainate receptor
A8C and L10C mutations (Wilding and Huettner, 2019), we in-
terpret these multiphasic currents as a composite response that
includes low-affinity inhibition superimposed on higher affinity
current activation. Potency of activation by Cd alone was similar
for A8Cmutant AMPA and kainate receptors, with half-maximal
values of 4.8 ± 1 µM for GluA1 A8C (Fig. 3 B) and 7.3 ± 1.4 µM for
GluK2 A8C (Wilding and Huettner, 2019), respectively. In con-
trast, the IC50 of 360 ± 80 µM for steady-state Cd-evoked current
(Fig. 3 B) revealed greater potency for inhibition of GluA1 A8C
compared with inhibition of WT GluA1 by millimolar Cd (Fig. 2
B) or of GluK2 A8C, which requires >10 mM Cd for steady-state
half-maximal inhibition (Wilding and Huettner, 2019). We
Figure 2. Cd inhibits WT GluA1. (A) Whole-cell current evoked by 100 µM
kainate (open bar) in an HEK293 cell cotransfected with GluA1 and stargazin.
The cyan bar indicates periods of Cd coapplication at 0.016, 0.08, 0.4, 2, or 10
mM. Inset shows the current–voltage relations for kainate alone or with
2 mM Cd in a cell transfected with GluA1. (B) Current recorded during Cd
coapplication plotted as a fraction of control current immediately before or
after Cd exposure (mean ± SEM; five cells for GluA1 alone, eight cells for
GluA1 plus γ-2 TARP). Smooth curves are best fit of I/I control = 1 / [1 + ([Cd] /
IC50)b], where IC50 is the Cd concentration that produced half-maximal in-
hibition and b is the slope factor.
Figure 3. Concentration dependence of GluA1 A8C activation and inhi-
bition. (A) Whole-cell currents evoked by increasing concentrations of Cd
from 640 nM to 2 mM in an HEK293 cell transfected with GluA1 A8C. (B)
Steady-state current recoded during exposure to each Cd concentration as a
fraction of the maximal Cd-evoked response (mean ± SEM; 12 cells). Smooth
curve is the best fit of I/I max = {1 / [1 + (EC50 / [Cd])n]} / [1+([Cd]/IC50)b],
where EC50 and IC50 are the Cd concentrations producing half-maximal ac-
tivation and inhibition, respectively; n and b are the slope factors for acti-
vation and inhibition.
Wilding and Huettner Journal of General Physiology 4 of 15
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performed more extensive tests for concentration dependence
of Cd action on the GluA1 L10C mutation, evaluating a range of
doses for Cd alone as well as Cd together with a fixed concen-
tration of 100 µM kainate on GluA1 L10C expressed alone or
together with γ-2 TARP. Compared with GluA1 A8C (Fig. 3), Cd
displayed lower potency for homomeric GluA1 with the L10C
mutation (Fig. 4; see also Wilding and Huettner, 2019). For re-
ceptors expressed without the auxiliary subunit, values for half-
maximal activation by Cd alone (Fig. 4 C, dark red circles) and
for potentiation of coapplied 100 µM kainate (Fig. 4 D, dark cyan
circles) were 400 ± 190 and 460 ± 180 µM, respectively, which
were not statistically superior to a simultaneous fit with a single
curve (EC50 = 420 ± 140 µM, n = 1.0 ± 0.2; P > 0.5, F-statistic).
The micromolar potency for Cd activation of GluA1 A8C and
GluK2 A8C indicates that Cd binding likely involves interaction
with at least two coordination groups (Puljung and Zagotta,
2011). In contrast, the weaker potency for activation of L10C
mutant receptors suggests that multiple coordination sites are
not required for Cd interaction with GluA1 L10C (Fig. 4) or GluK2
L10C (Wilding and Huettner, 2019), at least when these subunits
are expressed alone.
Coexpression of γ-2 TARP with GluA1 L10C enhanced po-
tency for Cd activation and enabled inhibition of steady-state
current at higher Cd concentrations (Fig. 4). Half-maximal ac-
tivation and inhibition for Cd alone (Fig. 4 C, bright red circles)
required 130 ± 30 µM and 3.8 ± 1 mM Cd, respectively, whereas
coapplication with 100 µM kainate (Fig. 4 D, bright cyan circles)
yielded significantly lower half-maximal values of 33 ± 6 µM for
the rising phase of Cd potentiation (P < 0.0001, t test) and 1.6 ±
0.3 mM for the decline in steady-state potentiation at higher Cd
doses (P = 0.02, t test). These results, together with the data in
Fig. 1, B and C, where effects of a fixed dose of Cd were plotted as
a fraction of agonist-evoked current, suggest that coapplication
with agonist increases Cd efficacy at GluA1 L10C, whereas co-
expression of γ-2 TARP increases Cd potency and agonist
coapplication only enhances Cd potency when γ-2 TARP is
coexpressed.
Figure 4. Concentration dependence of GluA1 L10C activation and in-
hibition. (A and B) Whole-cell currents evoked by 3.2 µM to 10 mM Cd in
HEK293 cells transfected with GluA1 L10C alone (A) or together with γ-2
TARP (B). (C and D) Steady-state Cd-evoked current relative to control for Cd
alone (C) or relative to kainate alone for Cd plus kainate applications (D),
plotted as a fraction of the maximal Cd-evoked response (mean ± SEM).
Smooth curves are the best fits of I/I max = m / [1 + (EC50 / [Cd])n] for GluA1
L10C alone or I/I max = {1 / [1+(EC50/[Cd])n]} / [1+([Cd]/IC50)b] for GluA1
L10C plus γ-2 TARP, where EC50 and IC50 are the Cd concentrations pro-
ducing half-maximal activation and inhibition, respectively; n and b are the
slope factors for activation and inhibition; m is a scaling factor steady-state
current less than the maximal response. For GluA1 L10C expressed alone, Cd
activated current with an EC50 of 400 ± 190 µM (n = 1.0 ± 0.3, six cells) when
applied alone (C, dark red circles) or 460 ± 180 µM (n = 1.0 ± 0.2, three cells)
when applied with 100 µM kainate (D, dark cyan circles). Cells cotransfected
with GluA1 L10C and γ-2 TARP were inhibited by high Cd concentrations and
activated by lower concentrations. For Cd alone (C, bright red circles, 10
cells), EC50 = 130 ± 30 µM (n = 1.7 ± 0.5) and IC50 = 3.8 ± 1 mM (b = 1.2 ± 0.4).
For Cd plus kainate (D, bright cyan circles, four cells), EC50 = 33 ± 6 µM (n =
1.6 ± 0.3) and IC50 = 1.6 ± 0.3 mM (b = 1.5 ± 0.4).
Wilding and Huettner Journal of General Physiology 5 of 15
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Partial occlusion by MTS reagents
Our previouswork onGluK2 A8C and L10C showed that activation
by Cd was substantially reduced after exposure to 2-aminoethyl
MTS (MTSEA; Wilding and Huettner, 2019), a sulfhydryl-reactive
compound that covalentlymodifies free Cys residues. Earlier work
on GluA1 A8C or L10C expressed in oocytes reported little
change in glutamate-evoked current following exposure to
MTSEA (Sobolevsky et al., 2003); however, to test whether Cd
activation of GluA1 A8C or L10C was affected by Cys modification
we evaluated currents before and after several minutes exposure
to kainate plus 100 µM MTSEA (Fig. 5). Plots in Fig. 5, C and D
summarize the effect of MTSEA exposure on activation by Cd
alone or together with 100 kainate, on activation by kainate
alone, and on the current required to hold cells at −80 mV. Both
mutant GluA1 subunits were tested in isolation as well as together
with coexpressed γ-2 TARP. For GluA1 A8C expressed alone,
exposure to MTSEA had little effect on the holding current but
reduced activation by Cd, kainate, or Cd plus kainate (Fig. 5 C).
MTSEAwas significantly less effective on GluA1 A8C coexpressed
with γ-2 TARP (Fig. 5, A and C; P = 0.0001, two-way ANOVA),
causing a slight reduction in current activated by Cd alone but no
significant change in current evoked by kainate alone or kainate
together with Cd (I after/I before ∼1). In contrast to the A8C
mutant, MTSEA had a larger negative effect on activation of
GluA1 L10C coexpressed with γ-2 TARP than on GluA1 L10C alone
(Fig. 5, B and D; P = 0.021, two-way ANOVA). In addition, cells
expressing GluA1 L10C, with or without γ-2 TARP, displayed a
significant increase in holding current following exposure to
MTSEA (Fig. 5, B and D; P < 0.0001, two-way ANOVA), as we
previously observed for the GluK2 L10C substitution (Wilding
and Huettner, 2019). Together, these results indicate at least
partial occlusion of Cd activation by MTS modification. Coex-
pression of γ-2 TARP suppressed this effect for GluA1 A8C but
enhanced it for GluA1 L10C. Lack of complete occlusion may be
owing to our use of a relatively low MTSEA concentration (100
µM) compared with previous work (Sobolevsky et al., 2003),
whereas the reason we observe a greater effect on GluA1 L10C
than previous reported in oocytes remains unclear.
Cd activates heteromeric AMPA receptors
Although homomeric iGluRs with one M3 mutation per subunit
will have a total of four introduced cysteines per receptor, our
Figure 5. MTSEA reduces Cd activation of GluA1 A8C and L10C. (A and B)Whole-cell currents evoked by 100 µM kainate (open bars) or 50 µM Cd alone
(red bars) or together with kainate (cyan bars) in HEK293 cells transfected with GluA1 A8C (A) or L10C (B) together with γ-2 TARP. (A and C) For the A8C
mutation, exposure to MTSEA (blue bars) together with kainate caused little change in holding current or kainate-evoked current but reduced subsequent
activation by Cd; the effect of MTS treatment was weaker in cells coexpressing γ-2 TARP (mean ± SEM; 6–29 cells per treatment). (B and D) For the L10C
substitution, MTS treatment had a stronger effect in cells cotransfected with γ-2 TARP and caused a significant increase in holding current (mean ± SEM; 6–11
cells per treatment). For comparison with Fig 1, B and C, the Cd alone/kainate alone and Cd plus kainate/kainate alone current ratios in these cells before
MTSEA exposure are shown in C and D. Asterisks denote significant difference with γ-2 TARP coexpression (one-way ANOVA with post hoc Student–
Newman–Keuls test). # indicates significant difference from (I after/I before) = 1.
Wilding and Huettner Journal of General Physiology 6 of 15
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previous work showed that all four substitutions are not re-
quired for Cd activation of GluK2 A8C or L10C (Wilding and
Huettner, 2019). To test whether AMPA receptors with fewer
than four cysteines near the bundle crossing can be activated by
Cd, we coexpressed mutant GluA1 A8C (Fig. 6) or L10C (Fig. 7)
together with WT edited GluA2(R). For both mutations, Cd ac-
tivated heteromeric receptors, albeit with lower potency than
for homomeric receptors with Cys substitutions on all four
subunits (compare Figs. 3 B and 6 B with Figs. 4 C and 7 D). Cells
cotransfected with the Q/R site-edited GluA2(R) subunit lacked
strong inward rectification (Fig. 7 B) observed for unedited ho-
momeric WT GluA1 (Boulter et al., 1990; Verdoorn et al., 1991) as
well as the A8C and L10C mutant subunits (Fig. S4). The ability
of Cd to activate heteromeric combinations indicates that Cys
substitution is not required on all four AMPA receptor subunits.
Cd activates NMDA receptors with A8C substitution
NMDA receptors are obligate heteromers, requiring coex-
pression of the GluN1 subunit together with GluN2 and/or
GluN3 subunits (Hansen et al., 2014; Pérez-Otaño et al., 2016). As
an initial test for activation of M3 mutant NMDA receptors, we
examined conventional diheteromeric channels formed by co-
transfection of GluN1 and GluN2B subunits. For WT receptors,
Figure 6. Cd activates GluA1 A8C/GluA2 heteromeric receptors. (A)
Whole-cell currents evoked by 3.2 µM to 10 mM Cd (red bars) or by 100 µM
kainate (open bars) in HEK293 cells cotransfected with edited GluA2 and GluA1
A8C. (B) Steady-state Cd-evoked current plotted as a fraction of the maximal
Cd-evoked response (mean ± SEM; five cells). Smooth curve is the best fits of I/I
max = {1 / [1 + (EC50 / [Cd])n]} / [1 + ([Cd] / IC50)b], where EC50 and IC50 are the
Cd concentrations producing half-maximal activation and inhibition, respec-
tively; n and b are the slope factors for activation and inhibition.
Figure 7. Cd activates GluA1 L10C/GluA2 heteromeric receptors. (A)
Whole-cell currents evoked by 100 µM kainate (open bars) and 50 µM Cd alone
(red bar) or together with kainate (cyan bar) in HEK293 cells cotransfected with
edited GluA2 and GluA1 L10C. (B) Current evoked by 100 µM kainate (black line)
or kainate plus 50 µM Cd (cyan line) during voltage ramps from −150 to +120
mV. (C)Whole-cell currents evoked by 3.2 µM to 10 mMCd (red bars) or by 100
µM kainate (open bars) in HEK293 cells cotransfected with edited GluA2, GluA1
L10C, and γ-2 TARP. (D) Steady-state Cd-evoked current plotted as a fraction of
the maximal Cd-evoked response (mean ± SEM; four cells with and five cells
without γ-2 TARP). Smooth curves are the best fits of I/I max = 1 / [1 + (EC50 /
[Cd])n] for GluA1 L10Cwith GluA2 or I/I max = {1 / [1 + (EC50 / [Cd])n]} / [1+([Cd] /
IC50)b] for GluA1 L10C with GluA2 and γ-2 TARP, where EC50 and IC50 are the Cd
concentrations producing half-maximal activation and inhibition, respectively; n
and b are the slope factors for activation and inhibition.
Wilding and Huettner Journal of General Physiology 7 of 15




 http://rupress.org/jgp/article-pdf/152/7/e201912537/1237874/jgp_201912537.pdf by W
ashington U
niversity In St. Louis Libraries user on 07 N
ovem
ber 2020
exposure to 50 µM Cd alone caused negligible change in holding
current, whereas coapplication with 10 µM NMDA and glycine
produced modest block (∼44.4%) of agonist-evoked current
(Fig. 8, A and E; see also Mayer et al., 1989; Tu et al., 2016;
Wilding and Huettner, 2019). In contrast, 50 µM Cd alone acti-
vated receptors with A8C substitution to GluN2B (Fig. 8, B and
E), GluN1 (Fig. 8, C and E), or both subunits (Fig. 8, D and E), and
coapplication of Cd potentiated current evoked by NMDA plus
glycine (Fig. 8). As for AMPA (Fig. 3) and kainate (Wilding and
Huettner, 2019) receptors, the A8C mutant NMDA receptors
exhibited monotonic activation and decay for currents elicited
by Cd concentrations <100 µM but increasing inhibition during
steady-state exposure to higher Cd concentrations (Fig. 9 A). For
cells cotransfected with both the N1 A8C and N2B A8C mutant
subunits, current activation by Cd alonewas half maximal at 24 ±
5 µM, whereas half-maximal steady-state inhibition required 1.5
± 0.4 mM Cd (Fig. 9, A and B). Thus, A8C substitution to either
two or all four of the subunits in a tetrameric channel enables
activation by Cd for all three of the iGluR subtypes.
Subunit-dependent potentiation by Cd at the +10 position
To test for Cd activation of NMDA receptors with Cys sub-
stitutions at the +10 position, we generated GluN1 L10C and
GluN2B M10C mutations and analyzed currents in cells trans-
fected with N1WT +N2BM10C, N1 L10C + N2BWT, or N1 L10C +
N2B M10C (Fig. 10). In contrast to kainate (Wilding and
Huettner, 2019) or AMPA (Figs. 1 and 4) receptors, Cd alone at
0.05, 0.5, and 5 mM failed to activate NMDA receptors with Cys
substitutions at the +10 position of GluN1, GluN2B, or both
subunits (Fig. 10 D).Moreover, coapplication of Cd together with
10 µM NMDA and glycine revealed striking differences among
the subunit combinations. Exposure to Cd potentiated agonist-
evoked currents mediated by mutant N1 L10C subunits com-
bined with WT N2B (Fig. 10, B and E). In contrast, Cd strongly
inhibited agonist-evoked current for receptors that included the
N2B M10C subunit, combined with either WT N1 (Fig. 10, A and
E) or N1 L10C (Fig. 10, C and E). Thus, for Cys substitution at the
+10 position positive allosteric modulation by Cd is restricted to
the N1 subunit, whereas Cd interaction with N2B M10C yields
dominant inhibition over N1 WT or N1 L10C.
Mg block and potentiation
To test whether Cys substitution and/or interaction with Cd
affects voltage-dependent channel block by Mg ions (Nowak
et al., 1984; Mayer et al., 1984), we analyzed currents evoked
by agonists and/or Cd in the presence and absence of 1 mM Mg
(Fig. 11). Currents were evaluated during triangle wave voltage
ramps from −150 to +120mV (Fig. 11, A and B; Lopez et al., 2013),
at steady-state holding potentials of −80 and +40 mV (Fig. 11 C),
or with brief voltage steps from −80 mV to positive test poten-
tials (Fig. 11 D). In cells transfected with WT receptor subunits,
agonist-evoked currents were strongly blocked by Mg at nega-
tive potentials but slightly potentiated at positive potentials
(Fig. 11, A and E), as previously reported (Paoletti et al., 1995) for
the diheteromeric combination that we used (GluN2B plus the
GluN1-1a splice variant that lacks extracellular exon 5; Hollmann
et al., 1993). Currents evoked by NMDA and glycine, by Cd alone,
or by Cd together with the agonists also were strongly blocked
by Mg at negative potentials in cells expressing receptors with
A8C substitution in the N1 subunit, the N2B subunit or both N1
and N2B (Fig. 11 E). Thus, replacement of A8 with Cys and in-
teraction with Cd do not prevent the movement of Mg ions past
the bundle crossing and into the central cavity at negative po-
tentials (see Kashiwagi et al., 2002; Yuan et al., 2005). Slight
potentiation by Mg at positive potentials (Paoletti et al., 1995)
was also observed for receptors that included the N2B A8C
Figure 8. Cd activation of A8C substituted NMDA receptors. (A–D)
Whole-cell currents evoked by 10 µM NMDA + 10 µM glycine (open bars), 50
µM Cd alone (red bars), or Cd together with agonists (cyan bars) in HEK293
cells cotransfected with WT GluN1 and GluN2B (A), GluN1 WT and GluN2B
A8C (B), GluN1 A8C and GluN2B WT (C), or GluN1 A8C and GluN2B A8C (D).
Holding potential is −80 mV. Scale bars represent 300 pA and 30 ms.
(E) Current evoked by 50 µM Cd alone (red bars) or together with 10 µM
NMDA plus 10 µM glycine (cyan bars) as a fraction of the current evoked by
agonist alone (mean ± SEM, 10–48 cells per construct). Note the log scale. All
of the mutant combinations were significantly different from WT but were
not significantly different from each other (ANOVA on ranks with post hoc
Dunn’s test).
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mutant subunit together with either WT GluN1 or GluN1 A8C
(Fig. 11 E). Interestingly, we observed significantly greater po-
tentiation by 1 mM Mg for the combination of GluN1 A8C
coexpressed with WT GluN2B (Fig. 11, B and E), suggesting a
specific linkage between GluN1 residues at the bundle crossing
and the positive allosteric modulation site within the N1/N2B
ATD dimer interface where Mg and polyamines bind (Mony
et al., 2011). As shown in Fig. 11, D and E, exposure to 1 mM
Mg yielded no potentiation of agonist evoked currents at posi-
tive potentials in cells cotransfected with GluN1 A8C and WT
GluN2A, which confirms that the strong Mg potentiation ob-
served for the N1 A8C + N2B WT combination involves a similar
mechanism to that previously reported for WT N1 + N2B re-
ceptors (Paoletti et al., 1995; Mony et al., 2011). Additional ex-
periments demonstrated intact voltage-dependent Mg block in
cells expressing receptors that included the N1L10C or N2BM10C
subunits (Fig. S5).
Acidic pH reduces Cd activation
Potentiation of N1/N2B NMDA receptors by Mg or polyamines
involves relief of tonic inhibition by protons (Traynelis et al.,
1995; Paoletti et al., 1995; Mony et al., 2011). Recent structural
analysis (Jalali-Yazdi et al., 2018; Regan et al., 2018; Zhang et al.,
2018) confirms earlier evidence (Gielen et al., 2009; Yuan et al.,
2009) that conformational changes in the ATD and LBD underlie
proton inhibition. In addition, however, mutations in the SY-
TANLAAF motif of both N1 and N2 subunits also can alter the
potency of proton inhibition (Low et al., 2003), highlighting the
mechanistic link between agonist binding and the bundle-
crossing gate (Ladislav et al., 2018; Wilding and Huettner,
2019). To test whether protons influence the action of Cd on
A8C or L10C mutant receptors we recorded currents during
exposure to NMDA and glycine alone or together with Cd at pH
6.6 and 8.0 in cells cotransfected with N1 A8C or N1 L10C with
WT N2A or N2B. As shown in Fig. 12, agonist-evoked currents
displayed robust enhancement by Cd at pH 8.0 but no significant
potentiation by Cd coapplication at pH 6.6. Thus, Cd does not act
by overcoming proton inhibition but instead exhibits inhibition
by protons as is observed for channel activation by agonist
(Traynelis et al., 1995).
Lowering the pH might reduce Cd activation by protonation
of the same sites that underlie inhibition of agonist-gated cur-
rents in WT receptors (Traynelis et al., 2010) or might reflect a
reduction in Cd coordination via direct protonation of the
substituted Cys side chains (Grimsley at al., 2009). To test
whether pH dependence of Cd activation was restricted to
NMDA receptors, we evaluated Cys-substituted AMPA and
kainate receptors at pH 6.6, where WT receptors exhibit modest
proton inhibition of agonist-gated currents (Ihle and Patneau,
2000; Lei et al., 2001; Mott et al., 2003). Whole-cell currents
evoked by 100 µM kainate in cells expressing A8C or L10C
mutant AMPA or kainate receptors were smaller at pH 6.6 than
at pH 7.4. Moreover, currents evoked by Cd in the A8C mutants
or by kainate plus Cd in the L10Cmutants were also significantly
reduced at pH 6.6 (Fig. S6), both in absolute terms as well as
relative to agonist-evoked current. Together, these results
demonstrate substantial proton inhibition of Cd-evoked cur-
rents in all three iGluR subtypes with A8C or L10C mutations.
Discussion
NMDA receptors exhibit physiological and pharmacological
properties distinct from AMPA and kainate receptors, which are
often grouped together as non-NMDA receptors owing to their
functional similarities and higher level of sequence identity
(Traynelis et al., 2010). All three iGluRs share a common mod-
ular organization and basic gating mechanism whereby agonist
binding changes the LBD conformation, exerting tension on
short linker segments that deform the M3 helix bundle crossing
and open a passage for ions and water into the pore (Twomey
and Sobolevsky, 2018). Early work revealed that side chains in
the conserved M3 SYTANLAAF sequence contribute to the
bundle crossing occlusion zone of all iGluRs (Zuo et al., 1997;
Kohda et al., 2000; Taverna et al., 2000; Wollmuth et al., 2000);
however, additional studies delineated motifs and specific
Figure 9. Concentration dependence of N1 A8C + N2B A8C activation.
(A) Whole-cell currents evoked by increasing concentrations of Cd from 640
nM to 10 mM in an HEK293 cell cotransfected with GluN1 A8C and GluN2B
A8C. (B) Steady-state current recoded during exposure to each Cd concen-
tration as a fraction of the maximal Cd-evoked response (mean ± SEM; 18
cells). Smooth curve is the best fit of I/I max = {1 / [1 + (EC50 / [Cd])n]} /
[1+([Cd]/IC50)b], where EC50 and IC50 are the Cd concentrations producing
half-maximal activation and inhibition, respectively; n and b are the slope
factors for activation and inhibition.
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Figure 10. Subunit-dependent potentiation for Cys substitution at the +10 position. (A–C)Whole-cell currents evoked by 10 µM NMDA + 10 µM glycine
(open bars) alone or together with coapplication of 50 µM, 500 µM, or 5 mM Cd (cyan bars, left to right) in HEK293 cells transfected with GluN1 WT + GluN2B
M10C (A), N1 L10C + N2BWT (B), or N1 L10C + N2B M10C (C). Holding potential is −80 mV. (D and E) Current recorded during exposure to Cd alone (D) or Cd
together with agonists (E) plotted as a fraction of current evoked by agonist alone (mean ± SEM, 4–21 cells per condition). Asterisks denote significant
difference from WT (one-way ANOVA with post hoc Dunn’s test). (D) Inset shows Application of 50 µM, 500 µM, and 5 mM Cd alone (red bars) caused little
change in holding current in a cell transfected with N1L10C + N2B WT.
Wilding and Huettner Journal of General Physiology 10 of 15
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residues within the LBD-TMD linkers and in the extracellular
portions of M1, M3, and M4 that underlie many of the important
functional and pharmacological differences between NMDA and
non-NMDA receptors (Watanabe et al., 2002; Low et al., 2003;
Chang and Kuo, 2008; Alsaloum et al., 2016; Ladislav et al., 2018;
Perszyk et al., 2018).
Our results with Cys substituted AMPA and NMDA receptors
in the present study, together with our earlier work on GluK2
kainate receptor A8C and L10C mutations (Wilding and
Huettner, 2019), identify a shared mechanism for prying open
iGluR bundle crossing gates independent of agonist binding to
the LBDs (Wollmuth, 2019). For all three iGluR subtypes, expo-
sure to Cd produced rapid and reversible activation of receptors
that included subunits with the A8C substitution. The potency of
activation for A8C mutant receptors, with half-maximal Cd
concentrations in the range of 5–25 µM, is consistent with Cd
coordination by at least two side chains (Puljung and Zagotta,
2011). In contrast, the higher Cd concentrations required for
activation of receptors with L10C substitutions indicate a lower
affinity interaction that may not require multiple coordinating
residues (Wilding and Huettner, 2019). Our results also show
that activation by Cd does not require Cys substitution on all four
of the subunits within a tetrameric iGluR. Potency for activation
by Cd was lower for receptors with fewer than four mutant
subunits, as predicted by simple kinetic models with different
numbers of binding sites (Wilding and Huettner, 2019). Impor-
tantly, Cd consistently activated A8C or L10C substituted heter-
omeric receptors that likely contain two mutant subunits
alternating with two WT subunits resulting in Cys substitutions
arranged diagonally across the pore axis (Greger and Mayer
2019).
For the A8C mutation, we do not know if a single Cd coor-
dinates with both substituted Cys residues, but such an ar-
rangement would place the coordinated Cd directly along the
pore axis (Wollmuth 2019) and would likely restrict the M3
helices from splaying apart (Wilding and Huettner, 2019). In-
stead, each substituted Cys may coordinate Cd with other native
residues nearby (Zhou et al., 2015; Tu et al., 2016). Our experi-
ments with A8C-substituted NMDA receptors demonstrate that
Mg coapplication produces voltage-dependent block of agonist
evoked currents (Nowak et al., 1984; Mayer et al., 1984) as well
as current elicited by Cd alone or Cd together with agonist,
suggesting that Cd coordination does not hinder passage of Mg
into the central cavity. This result is consistent with previous
work (Yuan et al., 2005; Chang and Kuo, 2008) showing per-
sistence of voltage-dependent Mg block for NMDA receptors
with bundle-crossing Cys substitutions after treatment with
MTSEA, a sulfhydryl-reactive agent that modifies free Cys res-
idues to yield a positively charged side chain approximately the
size of lysine (Akabas, 2015). Thus, addition of positive charge at
the bundle crossing does not preclude the passage of cations,
including larger polyvalent cations such as Mg.
Figure 11. Mg block and potentiation. (A and B) Current–voltage relations
recorded during voltage ramps from −150 to +120 mV in cells transfected
with N2B WT and either N1 WT (A) or N1 A8C (B). (C) Outward current
evoked by NMDA + glycine (open bar) and with 1 mM Mg (blue bar) while
holding steady at +40 mV in an HEK293 cell transfected with N1 A8C + N2B
WT. (D) Current evoked by NMDA + glycine alone (open bar) or with 50 µM
Cd (cyan bar) in a cell expressing N1 A8C and N2AWT. Traces depict currents
averaged over 2.5-ms intervals while holding at −80 mV and during 50-ms
steps to +40 mV delivered at 5 Hz. Blue bars indicate coapplication of 1 mM
Mg. (E) Summary plot of currents (mean ± SEM, 5–16 cells per construct)
evoked at −80 and +40 mV in the presence of 1 mM Mg as a fraction of
current in Mg-free solution for NMDA + glycine and for Cd alone or together
with agonist. * denotes significant difference from I Mg/I Mg-free = 1 (t test).
** denotes significant difference from N1 WT + N2B WT (one-way ANOVA
with post hoc Dunn’s test). # indicates significant difference from I Mg/I Mg-free
= 0 (t test).
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Initial evidence that the residue at position 8 is important for
iGluR gating came from study of Lurcher mutant mice, which
have a missense mutation that introduces an A8T substitution in
the orphan delta-2 iGluR subunit (Zuo et al., 1997). Cells ex-
pressing this mutant subunit exhibit constitutive channel ac-
tivity (Kohda et al., 2000; Wollmuth et al., 2000; Schwarz et al.,
2001). Homologous A8T substitution in AMPA and kainate re-
ceptor subunits reduces desensitization, slows deactivation, in-
creases affinity for agonists, and promotes variable levels of
constitutive channel opening (Kohda et al., 2000; Taverna et al.,
2000; Klein and Howe, 2004). For NMDA receptors, A8T sub-
stitution in either GluN1 or GluN2 reduces receptor inhibition
by protons (Low et al., 2003), but A8 replacement in GluN2
has negligible effect on receptor activation, desensitization, or
deactivation, and A8 substitution in GluN1 causes only modest
changes in these parameters (Kohda et al., 2000; Hu and Zheng,
2005; Murthy et al., 2012) compared with much larger effects
produced by GluN1 or GluN2 substitutions at the adjacent A7
position (Jones et al., 2002; Yuan et al., 2005; Blanke and
VanDongen, 2008; Murthy et al., 2012; Tu and Kuo, 2015) or
other nearby residues (Chang and Kuo, 2008; Ladislav et al.,
2018).
Our results demonstrate Cd activation for NMDA receptors
with A8C substitution to both the N1 and N2 subunit or to either
subunit alone, but we also identified two unique features for
receptors that included WT GluN2 coexpressed with A8C or
L10C substitutions only on the N1 subunit. First, Cd enhanced
agonist-evoked current in cells coexpressing N1 L10C together
with WT N2B or N2A but inhibited currents in cells that re-
ceived N2B M10C together with either N1 L10C or N1 WT. Sec-
ond, exposure to Mg produced significantly greater potentiation
in cells cotransfected with N1A8C and N2B WT, whereas coex-
pression of N2B A8C with either N1 A8C or N1 WT exhibited the
same potentiation as receptors in which both N1 and N2B sub-
units were WT (Paoletti et al., 1995). It is notable that in both
cases where Cys-substituted N1 subunits yield a novel pheno-
type when coexpressed with WT N2B, the corresponding Cys-
substituted N2B phenotype dominates when coexpressed with
either WT or mutant N1. These differences likely reflect the
asymmetric conformations of N1 and N2 subunits within the
heterotetramer (Karakas and Furukawa, 2014; Lee et al., 2014).
GluN1 subunits adopt the A/C conformation (Sobolevsky et al.,
2009) with linkers from M3 extending up toward the LBD,
whereas GluN2 subunits are in the B/D conformation, with their
M3 linkers oriented almost perpendicular to the pore axis. In-
creasing evidence suggests that subunits in the B/D conforma-
tion play the major role in control of gating (Murthy et al., 2012;
Kazi et al., 2014; Tu and Kuo, 2015) consistent with the greater
deformation observed for B/D subunit M3 helices when iGluRs
open (Chen et al., 2017; Twomey et al., 2017). Importantly, re-
ceptors formed by cotransfection N1A8C with N2A WT were
activated by Cd but displayed no potentiation by Mg as previ-
ously shown for N1WT/N2AWT receptors (Paoletti et al., 1995).
This result demonstrates that receptor activation or potentiation
by Cd is distinct from potentiation by Mg because N1 A8C/N2A
WT receptors respond to Cd but lack potentiation by Mg. In
addition, our results suggest that greater Mg potentiation ob-
served for N1 A8C/N2B WT likely involves an enhancement of
the same N2B-specific relief from proton inhibition that un-
derlies Mg potentiation of WT N1/N2B diheteromers (Mony
et al., 2011). Our results also show that in contrast to Mg, the
activation of Cys-substituted iGluRs by Cd is strongly inhibited
by protons, with Cd having minimal effect on A8C or L10C
mutant AMPA, kainate, or NMDA receptors at pH 6.6.
Numerous previous studies have delineated the changes in-
duced by γ-2 TARP coexpression on AMPA receptor agonist-
evoked currents, including increases in agonist potency and
partial agonist efficacy (Jackson and Nicoll, 2011; Greger et al.,
2017). Our results reveal substantial effects of γ-2 TARP on Cd
activation of M3 mutant homomeric and heteromeric AMPA
receptors. TARP coexpression reduced allosteric potentiation of
Figure 12. Protons inhibit Cd potentiation of NMDA receptors with M3
helix Cys substitutions. (A and B)Whole-cell currents evoked at pH 8.0 (A)
or pH 6.6 (B) by 10 µM NMDA and glycine (open bars) alone or together with
400 µM Cd (cyan bars) in HEK293 cells cotransfected with N1 L10C and either
N2B WT (A) or N2A WT (B). (C) Summary plot of currents (mean ± SEM, four
to seven cells per construct) evoked at −80 and +60mV by NMDA + glycine +
Cd as a fraction of NMDA + glycine alone, at pH 8.0 or pH 6.6. The difference
between pH 8.0 and pH 6.6 was significant for each construct combination
(paired t test). In addition, at pH 8.0, the (I N+g+Cd / I N+g) ratio was signifi-
cantly larger for N1A8C coexpressed with N2AWT than with N2BWT (t test).
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agonist-gated currents by Cd for GluA1 A8C or L10C and pro-
tected receptors with the A8C mutation from modification by
MTSEA. In contrast, for receptors with the L10C mutation,
treatment with MTSEA produced a larger decline in activation
by agonist and/or Cd in cells cotransfected with γ-2 TARP than
in cells expressing GluA1 L10C alone. In addition, TARP coex-
pression increased the apparent affinity for Cd activation of
GluA1 L10C and promoted inhibition by higher doses of Cd
compared with receptors expressed without γ-2 TARP.
Conclusions
Our results demonstrate that AMPA, NMDA, and kainate re-
ceptor channels with specific M3 Cys substitutions can be pried
open by exposure to cadmium independent of agonist occu-
pancy. Cd activates channels with A8C substitution to subunits
in either the A/C or B/D conformation, despite asymmetry in the
heteromeric NMDA receptor TMD (Sobolevsky et al., 2007;
Karakas and Furukawa, 2014; Lee et al., 2014) and marked
asymmetry in the arrangement of distal M3 residues in the
open-state structure of homomeric AMPA receptors (Chen et al.,
2017; Twomey et al., 2017). For NMDA receptors, but not AMPA
or kainate receptors, we observe asymmetric effects of Cd on
subunits with Cys substitution at the +10 position. Consistent
with previous work (Murthy et al., 2012; Kazi et al., 2014; Tu and
Kuo, 2015), the GluN2 subunit was dominant over GluN1. Sur-
prisingly, however, GluN2 dominance was most striking in cases
where novel phenotypes produced by GluN1 L10C were sup-
pressed by coexpression of GluN2B M10C. Further work on
these and other (Hu et al., 2016) mutations near the bundle
crossingmay aid in the design of therapeutic agents by revealing
structural rearrangements that underlie novel channel open
conformations.
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Figure S1. Cd reduces holding current in A7C mutant GluK2(Q) or GluA1. (A)Whole-cell current during exposure to 10 µM kainate (open bars) or 100 µM
Cd (red bars) in an HEK293 cell transfected with GluK2(Q) A7C. Note the slow recovery from Cd inhibition in the absence and presence of kainate. (B) Current
during exposure to 100 µM kainate or 50 µM Cd in a cell cotransfected with GluA1 A7C and γ-2 TARP.
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Figure S2. Activation by kainate or glutamate plus cyclothiazide. Summary plot of current (mean ± SEM, 5–14 cells per construct) evoked by 100 µM
kainate or by 1 mM glutamate plus 30 µM cyclothiazide in HEK293 cells transfected with WT, A8C, or L10C mutant GluA1, alone or cotransfected with γ-2
TARP. *, both A8C and L10Cmutants were significantly different fromWT; †, A8C was significantly different from L10C; #, L10Cwith γ-2 TARPwas significantly
different from L10C alone two-way ANOVA with post hoc Student–Newman-Keuls test).
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Figure S3. Activation by Cd compared with glutamate. (A) Whole-cell current evoked by 1 mM glutamate (open bars), 50 µM or 500 µM Cd alone (red
bars), or together with glutamate (cyan bars) in a cell cotransfected with GluA1 L10C and γ-2 TARP. (B) Summary plot of current (mean ± SEM, 5–12 cells per
construct) evoked by Cd alone or Cd plus glutamate as a fraction of current evoked by glutamate alone. * denotes significant difference between A8C and L10C.
# indicates significant difference with γ-2 TARP coexpression (two-way ANOVA with post hoc Student–Newman-Keuls test).
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Figure S4. Inward rectification of GluA1 A8C and L10C. (A–D) Currents evoked by 100 µM kainate, 400 µM Cd alone or together with kainate during
voltage ramps from −150 to +120mV. (E) Rectification index (mean ± SEM ratio of current at −60mV to +40mV; 5–11 cells per construct) for currents evoke by
kainate, Cd alone, or together with kainate. Higher index values indicate stronger rectification. Values for GluA1 L10C + γ-2 TARPwere significantly greater than
for GluA1 A8C expressed alone or together with γ-2 (2-way ANOVA with post hoc Student–Newman–Keuls test).
Wilding and Huettner Journal of General Physiology S4
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Figure S5. Mg block of NMDA receptors with N1 L10C or N2B M10C mutations. (A) Whole-cell currents evoked by 10 µM NMDA + glycine alone (open
bar) or together with 500 µM Cd (cyan bar) in a cell cotransfected with N1 L10C and N2B WT. Blue bars indicate coapplication of 1 mM Mg. Traces depict
current averaged over 2.5-ms intervals while holding at −80 mV and during 50-ms steps to +40 mV delivered at 5 Hz. (B) Summary plot of currents (mean ±
SEM, four to six cells per construct) evoked at −80 and +40 mV in the presence of 1 mM Mg as a fraction of current in Mg-free solution for NMDA + glycine
alone or together with Cd. * denotes significant difference from I N+g+Mg/I N+g = 1 (t test). # denotes significant difference from I N+g+Mg/I N+g = 0 (t test).
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Figure S6. Protons inhibit Cd activation of Cys substituted AMPA and kainate receptors. Current (mean ± SEM, 5–39 cells per condition) evoked by Cd
alone or together with kainate as a fraction of current evoked by kainate alone. Homomeric receptors with A8C (left) or L10C (right) substitutions were tested
at different external pH levels in HEK293 cells transfected with mutant GluK2 (open bars) or cotransfected with mutant GluA1 and stargazin (γ-2 TARP; gray
bars). * denotes significant difference from pH 8.0 and 7.4 (ANOVA on ranks with post hoc Dunn’s test). # denotes significant difference from pH 7.4
(Mann–Whitney rank sum test).
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